Skip to content
Sign in
Artwork for Pharma Sessions
Pharma Sessions · July 31 · 38 min

Hallway Interviews with Pharma Learning Leaders

Pharma Sessions — ACTO Client Summit: Hallway Interviews At ACTO's 2026 client summit in Boston, we pulled some incredible minds out of the hallway for quick, candid conversations about where field excellence, AI, and learning & development are headed. No scripts, no slides — just honest takes from the people doing the work. In this episode, you'll hear from six pharma L&D leaders on how AI is changing their roles, what they're doing differently at national sales meetings, the adoption challenges they're navigating, and why L&D may be the most strategically important function in any AI rollout. Timestamps: 1:43 — Andrea Penn, Senior Director of Field Training & Customer Training, Autolus Therapeutics 7:38 — Sarah Barrett, Associate Director of Medical Affairs Training, Alnylam Pharmaceuticals 13:10 — Brian McCann, Dupixent Market Access Training, Regeneron 18:49 — Nicole Payne, Director of Global Commercial L&D, BioMarin 23:08 — Erin Gigliello, Senior Product Owner & Project Manager in L&D, Accord Biopharma 30:48 — Chris Richards, Head of Commercial L&D, Nuvations Bio Pharma Sessions is hosted by Jonathan Kaskey Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/ Or join the Pharma Sessions Substack: www.pharmasessions.substack.com

0:00-38:42
Play in
Transcript file

transcript

No transcript — this publisher did not publish one.

show notes

Pharma Sessions — ACTO Client Summit: Hallway Interviews

At ACTO's 2026 client summit in Boston, we pulled some incredible minds out of the hallway for quick, candid conversations about where field excellence, AI, and learning & development are headed. No scripts, no slides — just honest takes from the people doing the work.

In this episode, you'll hear from six pharma L&D leaders on how AI is changing their roles, what they're doing differently at national sales meetings, the adoption challenges they're navigating, and why L&D may be the most strategically important function in any AI rollout.

Timestamps:

  • 1:43 — Andrea Penn, Senior Director of Field Training & Customer Training, Autolus Therapeutics
  • 7:38 — Sarah Barrett, Associate Director of Medical Affairs Training, Alnylam Pharmaceuticals
  • 13:10 — Brian McCann, Dupixent Market Access Training, Regeneron
  • 18:49 — Nicole Payne, Director of Global Commercial L&D, BioMarin
  • 23:08 — Erin Gigliello, Senior Product Owner & Project Manager in L&D, Accord Biopharma
  • 30:48 — Chris Richards, Head of Commercial L&D, Nuvations Bio

Pharma Sessions is hosted by Jonathan Kaskey

Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

Or join the Pharma Sessions Substack:
www.pharmasessions.substack.com

links2

more episodes

All episodes